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Introduction: The bacterial overgrowth in the intestine, disruption of the balance
in the gut microbiota (dysbiosis) may have an effect on NAFLD pathogenesis.
The purpose of the present study is to compare the gut microbiota of the patients
with NAFLD and the healthy controls by quantitative Real Time PCR (qPCR)
analysis. Gut microbiota is affected by environmental and specific dietary pat-
terns. This is the first study in Turkish NAFLD patients with diverse cultural
dietetic habits. In order to understand the potential role of gut dysbiosis and
subsequent translocation of bacterial products, serum endotoxin levels were also
analyzed.
Aims & Methods: The stool and serum samples from 52 NAFLD patients and 38
healthy controls have been collected. qPCR analysis of Akkermansia muciniphila,
Faecalibacterium prausnitzii, Lactobacillus spp., Bifidobacterium spp., Bacteroides
fragilis group was performed. Serum endotoxin levels were also determined by
Chromogenic LAL Assay. Dietary habits were analysed by nutritional
questionnairs.
Results: Akkermansia muciniphila and Bacteroides fragilis group were signifi-
cantly lower in patients with NAFLD as compared with the healthy control
(p5 0.001). No significant difference was determined in terms of Lactobacillus
spp., Bifidobacterium spp. and Faecalibacterium prausnitzii counts. Moreover,
significantly elevated endotoxin levels were determined in NAFLD patients
(9.04EU/mL in NAFLD group; 2.75EU/mL in control group; p5 0.05).
Conclusion: Akkermansia muciniphila and Bacteroides fragilis group has been
known to have beneficial effects on gut barrier function. These two bacterial
groups were decreased in Turkish NAFLD patients. Decreased levels of these
bacteria were also shown in metabolic syndrome, which is frequently associated
with NAFLD. NAFLD patients have also increased endotoxin levels which indi-
cate a translocation of bacterial products as a result of increased gut permeability.
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Introduction: Current guidelindes recommend the use of 3rd generation cephalos-
porines for antibiotic therapy of spontaneous bacterial peritonitis (SBP).
Response rates to this therapy are reported with 76–98%. Bacterial translocation
of grampositive bacteria including enterococcae and specific local resistance pat-
terns may result in inferior response rates to 3rd generation cephalosporines.
Knowledge on local microbial epidemiology privides evidence to optimize anti-
biotic therapy.
Aims & Methods: Microbial epidemiology of ascitic fluid cultures and resistance
patterns obtained from patients with liver cirrhosis between 2013–2015 at a
tertiary care center (Krankenanstalt Rudolfstifung, Vienna) were retrospectively
analyzed.
Results: In total 482 ascites cultures of 200 cirrhotic patients were analyzed.
Median age was 62.2 (31.2–91.8) years, the majority (73%, M:146/F:54) were
men, and the main etiology was alcoholic liver disease (83% ALD), followed by
viral hepatitis (8.9%), autoimmunie (0.8%), and cryptogenic (7.3%). Thirty-one
(6.4%) of ascitic fluid cultures reveiled positive results, and 12.5% of all patients
(25/200) had at least one positive culture result. While 17 (3.5%) of patients had
bacteriascites, 58 (12%) of patients had SBP – among those 47 (81%) had no
germ isolated at their asicitic fluid culture. The most common species were
Streptococcus spp. (n¼ 7/22.6%) followed by Candida spp. (n¼ 6/19.4%),
E. coli and Staphylococci (n¼ 5/16.1%) and Enterococci (n¼ 3/9.7%). 28% of
all bacteria were resistant towards aminopenicillines/betalactamase-inhibitors.
There was a resistance rate of 18.5% of all germs towards 3rd generation
cephalosporines.
Conclusion: Considering the local microbial epidemiology, the initial empirical
antibiotic treatment for SBP should have good efficacy from grampositive bac-
teria including Enterococci. The recommendation for empiric antibiotic therapy
of patients with liver cirrhosis with inherent immunosuppression should be
adapted according to local resistance rates.
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Introduction: The innate immune system is of crucial importance for the regula-
tion of liver regeneration. Nucleic acid sensors are know to play a major role
within this context, however, there is only limited knowledge on the role of
central adaptor proteins, such as CARDIF and STING, during liver regenera-
tion. The aim of the present study was to analyze CARDIF and STING during
liver regeneration. Our hypothesis states that these known modulators of the
innate immune system have an influence on liver regeneration by direct activation
of CARDIF/STING-dependent cytosolic sensors.
Aims & Methods: In order to examine the influence of these two proteins on liver
regeneration, we use a newly established CARDIF/STING knockout mouse
model and compared it to a C57BL/6 mice control cohort. A 2/3 partial hepa-
tectomy (PH) was performed in both groups and mice were analyzed at eight
designated timepoints after surgery (n¼ 80 mice in total). Liver regeneration was
quantified by liver-to-body weight ratio, while proliferation was determined by
BrdU staining. Additionally, RNA- and protein levels of proliferation markers
were analyzed in resected tissues while pro-inflammatory cytokines were mea-
sured in murine serum.
Results: CARDIF/STING knockout mice showed a significantly impaired liver
regeneration after PH. Additionally, we detected a strong difference in BrdU
staining at several time points after PH underlining an inhibition of proliferation
in the absence of CARDIF and STING. Expression analysis of Interleukin-6 (IL-
6) revealed a significant decrease in the wild type cohort after PH. In addition,
the membrane-bound form of the IL-6 receptor was found to be increased in the
control group 2, 4 and 8 h after PH, while the soluble form of the receptor was
significantly increased 12 h post-PH. In CARDIF/STING knockout mice, the
proliferation marker Cyclin D1 was decreased until 24 hours after surgery, while
p21Cip1 expression, which is associated with a cell cycle arrest, was increased 8 h
post-PH.
Conclusion: Together, these data provide the first experimental evidence that
CARDIF/STING knockout mice show a delayed liver regeneration. These
data support the concept that CARDIF and STING play a major role in liver
regeneration during physiological conditions. In the absence of these two pro-
teins, we observed a modulated immune response which lead to a negative reg-
ulation of the proliferative capacity in liver after partial hepatectomy. This
finding could impact on the future development of molecular therapies making
use of the innate immune system.
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Introduction: Actual problem of modern hepatology is to find a new treatment
for liver diseases. Nowadays gene and cell therapy methods using hepatic stellate
cells (HSCs) that are thought to be regional stem cells of the liver, are considered
as a new perspective approach. It is assumed that using genetically modified cells
that express and overexpress therapeutic factors, could reduce the therapeutic
dose of transplanted cells and enhance therapeutic effects of these cells. However,
it remains unclear, the influence of genetically modified cells, in this case HSCs,
on liver regeneration and therapeutic effects of these cells after transplantation
into the organism.
Aims & Methods: We aimed to study the role of genetically modified HSCs (by
using the adenoviral vector Ad5-optHGF-optFGF4-RFP) on liver regeneration
after transplantation into the rats with acute liver damage. Genetic modification
of HSC was carried out by using adenoviral vector Ad5-optHGF-optFGF4-
RFP, which contains hepatocyte growth factor (HGF), fibroblast growth
factor-4 (FGF-4), and red fluorescent protein (RFP). We selected the classical
model of acute liver damage – partial hepatectomy (PH). Genetically modified
HSC were injected into portal vein during the PH operation. Control group of
animals have received the same cells without PH operation. The animals were
sacrificed after 1, 2, 3, 5, 7, 14, 28 days after the transplantation of HSC. Paraffin
slices were stained by immunohistochemistry with antibodies to RFP, desmin –
marker of HSC and a-SMA – myofibroblast marker.
Results: RFPþ cells were detected in parenchyma in both groups even at first
days after transplantation. They varied in shape and location in the liver in
different days of experiment. Small oval-shaped RFPþ cells were stained from
the first day near the portal tracts. At the same time hepatocyte-like RFPþ cells
were also found here from the first day. Maximal number of such cells was found
on the 5th day after transplantation in both groups, but in the experimental group
average number of cells was higher than in control. Coincidently, the intensity
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and quickness of hepatocyte repopulation in liver were higher in the group of
animal after PH. Number of desminþ cells increased more in the experimental
group comparing with the control one. In both groups a-SMA-positive cells were
not detected.
Conclusion:Genetically modified HSCs, which is transduced by HGF and FGF-4
genes, save their viability after transplantation into the rat after PH, migrate and
integrate into the liver parenchyma. These cells have a positive influence on the
process of liver regeneration without the risk of liver fibrosis.
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Introduction: The pathogenesis of non alcoholic fatty liver disease (NAFLD) has
not been well demonstrated yet, however, genetic predisposition is probably of
major importance. Angiotensin II type I receptor (AGTR1) have been known to
be involved in the process of liver fibrosis and metabolic syndrome.
Aims & Methods: This study aimed to investigate the association between
AGTR1 A1166C polymorphism and NAFLD. A cross-sectional study was con-
ducted between March 2014 and March 2015 among healthy adult individuals
referred to our radiology clinic for abdominal ultrasonography. NAFLD was
diagnosed by an expert radiologist based on the presence of these ultrasono-
graphic findings: hepatorenal echo contrast, liver brightness, deep attenuation,
vascular blurring and the absence of hepatitis B surface antigen or antibody to
hepatitis C virus, 2) alcohol consumption (420 g/day), 3) history of other causes
of liver disease, and 4) medications known to produce fatty liver disease during
the last six months prior to the study. Participants’ characteristics and their lab
data including liver function tests, lipid profile, fasting plasma glucose (FPG)
were also recorded. AGTR1 A1166C polymorphism was checked in subjects with
NAFLD and healthy controls using TaqMan allelic discrimination method.
Results: Fifty eight subjects with NAFLD were compared with 88 individuals
without NAFLD. Mean of all anthropometric indices including BMI, weight,
height, waist circumference and hip circumference were significantly higher in
subjects with NAFLD compared to those without NAFLD (P5 0.05). Mean
total cholesterol was significantly higher in subjects with NAFLD in comparison
to the controls in univariate analysis (P¼ 0.018). Higher serum ALT was also a
predictor of NAFLD (38.56 17.61 versus20.76 6.40 IU/L) (P¼ 0.0001).
Metabolic syndrome was detected in 31 (53.44%) individuals in NAFLD
group and in 27 (19.01%) in control group (P5 0.001) (OR: 3.51, 95% CI:
1.84–6.66). Multivariate logistic regression analysis of risk factors showed that
body mass index (BMI), metabolic syndrome, waist circumference, hip circum-
ference and serum ALT were independent predictors of NAFLD in our study
population. The frequency of AA and CC genotypes of AGTR1 gene was sig-
nificantly higher in patients with NAFLD compared to controls (P¼ 0.029 and
P¼ 0.042 respectively). Furthermore, C allele was more detected in subjects with
NAFLD compared to healthy controls (OR: 2.1; 95% CI: 1.23–3.61, P-
Value¼ 0.006). CC genotype (OR: 10.62; 95 %CI: 1.05–106.57, P-Value: 0.045)
and C allele (OR: 6.81; 95 %CI: 1.42- 32.48, P-Value: 0.016) were also predictors
of severe fatty liver disease in our study population.
Conclusion: Our results provide the first evidence that AGTR1 gene A1166C
polymorphism not only is associated with NAFLD and but also may predict
its severity. Multivariate regression analysis for the NAFLD predictors.
OR (95% CI) P-value
Body mass index (BMI) 7.74 (1.25-3.73) 0.005
Waist circumference 9.26 (0.68–0.92) 0.002
Hip circumference 5.21 (1.02–1.39) 0.022
Metabolic syndrome 15.21 (9.74–14.43) 50.001
Alanine aminotransferase (ALT) 26.46 (1.19–1.50) 50.001
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Introduction: Progressive growth of hepatic cysts can lead to symptomatic hepa-
tomegaly in polycystic liver disease (PLD).
Aims & Methods: Our primary aim was to determine at which threshold of liver
volume PLD patients become symptomatic. As a secondary objective we inves-
tigated which symptoms are associated with higher liver volume. We used the
PLD questionnaire (PLD-Q), a validated questionnaire that assesses frequency
and discomfort of PLD-related symptoms, to determine the symptom burden. In
a cohort of 291 PLD patients that have completed the PLD-Q and rated them-
selves as symptomatic or not (NCT02173080), we have defined the PLD-Q cut-
off value of being symptomatic with receiver operating characteristic (ROC)
analysis. The optimal PLD-Q cut-off score was 31 points with an area under
the curve (AUC) of 0.832 (p5 0.001). Next, we used baseline data of PLD
patients from two prospective studies (DIPAK observational study and
CURSOR randomized controlled trial (NCT02021110). All patients completed
the PLD-Q and had liver volume imaging (CT or MRI) measured by segmenta-
tion. In order to determine the liver volume cut-off value for being symptomatic,
we used the PLD-Q cut-off value from the previous step in another ROC analysis
with liver volume as independent variable. Spearman correlations were calculated
between symptoms and liver volume.
Results: We included 82 of the 131 patients from the prospective studies (main
exclusions: no PLD n¼ 26, no PLD-Q n¼ 7 or no imaging n¼ 8). Most patients
were female (n¼ 67) with a mean age of 48 years. Median liver volume was
3879mL (IQR: 2452 – 5891). Cut-off liver volume for being symptomatic was
3472mL (AUC 0.805, p5 0.001) with a sensitivity of 80% and a specificity of
73%. This cut-off volume has a positive and negative predictive value of 66%
and 82% respectively. Dissatisfaction with abdomen size was strongly correlated
with liver volume (r¼ 0.63). Fullness, early satiety, pain in rib cage, shortness of
breath, limited mobility, anxiety about the future and, problems with intercourse
correlated moderately (r¼ 0.40–0.59). There was a weak correlation with lack of
appetite, pain in side and tiredness (r¼ 0.20–0.39). Nausea (r¼ 0.17, p¼ 0.146)
and abdominal pain (r¼ 0.17, p¼ 0.127) were not correlated with liver volume.
Conclusion: Patients with liver volumes equivalent to two times the normal size
are likely to develop PLD-related symptoms. In patients with smaller livers, other
causes that lead to similar symptoms should be considered. Most PLD-related
symptoms are associated with larger liver volume, except for nausea and abdom-
inal pain.
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Introduction: Non-alcoholic fatty liver disease (NAFLD) is one of the most
prevalent chronic liver diseases worldwide with unclear mechanism. Long non-
coding RNAs (lncRNAs) have recently emerged as important regulatory mole-
cules in liver diseases.
Aims & Methods: To further understand the pathogenesis of NAFLD, lncRNA
and mRNA microarray was conducted in NAFLD mice model. Potential target
genes of significantly changed lncRNA were predicted using cis/trans-regulatory
algorithms, followed by Gene Ontology analysis and KEGG pathway enrich-
ment analysis. NAFLD mice model and NAFLD AML12 cell model were used
in further experiments. Real-time qPCR and Western Blot were adopted in
effect test after manipulations with certain siRNA or shRNA transfection. Oil
Red O/ HE staining and total triglyceroil kit were applicated in celllular steatosis
evaluation. Dual luciferase assay was used in identifying promoter activity of
certain genes.
Results: In current analysis, 89 up-regulated and 177 down-regulated mRNAs
were identified, together with 291 dysregulated lncRNAs. Bioinformatic analysis
of these RNAs has categorized these RNAs into pathways including arachidonic
acid metabolism, circadian rhythm, linoleic acid metabolism, Peroxisome
Proliferator Activated Receptor signaling pathway, sphingolipid metabolism,
steroid biosynthesis, tryptophan metabolism and tyrosine metabolism were com-
promised. Quantative PCR of 9 mRNAs and 8 lncRNAs of interest (named as
fatty liver related lncRNA, FLRL) was conducted and verified previous micro-
array results. Several lncRNAs, such as FLRL1, FLRL6 and FLRL2 demon-
strated to be likely a key player in circadian rhythm targeting Per3, Per2 and
Arntl. While FLRL8, FLRL3 and FLRL7 showed their potential role in PPAR
signaling pathway through interaction with Fabp5, Lpl and Fads2. Mechanism
of FLRL2 as well as its potential target circadian rhythm gene Arntl was inves-
tigated. Western blot and qPCR both revealed a decreased trend of FLRL2 as
well as Arntl in NAFLD in vivo, in vitro models. Overexpression of FLRL2
reverses lipid accumulation, ER stress and lipogenesis, which are main
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